Id |
Subject |
Object |
Predicate |
Lexical cue |
T6 |
0-8 |
Sentence |
denotes |
ABSTRACT |
T7 |
9-20 |
Sentence |
denotes |
Background: |
T8 |
21-196 |
Sentence |
denotes |
Molecular detection of SARS-CoV-2 in respiratory samples is the gold standard for COVID-19 diagnosis but it has a long turnaround time and struggles to detect low viral loads. |
T9 |
197-279 |
Sentence |
denotes |
Serology could help to diagnose suspected cases which lack molecular confirmation. |
T10 |
280-327 |
Sentence |
denotes |
Two case reports are presented as illustration. |
T11 |
328-339 |
Sentence |
denotes |
Objectives: |
T12 |
340-445 |
Sentence |
denotes |
The aim of this study was to evaluate the performance of several commercial assays for COVID-19 serology. |
T13 |
446-561 |
Sentence |
denotes |
We illustrated the added value of COVID-19 serology testing in suspect COVID-19 cases with negative molecular test. |
T14 |
562-575 |
Sentence |
denotes |
Study design: |
T15 |
576-700 |
Sentence |
denotes |
Twenty-three sera from 7 patients with a confirmed molecular diagnosis of SARS-CoV-2 were tested using 14 commercial assays. |
T16 |
701-788 |
Sentence |
denotes |
Additionally, 10 pre-pandemic sera and 9 potentially cross-reactive sera were selected. |
T17 |
789-831 |
Sentence |
denotes |
We calculated sensitivity and specificity. |
T18 |
832-1026 |
Sentence |
denotes |
Furthermore, we discuss the diagnostic relevance of COVID-19 serology in a retrospective cohort of 145 COVID-19 cases in which repetitive molecular and serological SARS-CoV-2 tests were applied. |
T19 |
1027-1035 |
Sentence |
denotes |
Results: |
T20 |
1036-1175 |
Sentence |
denotes |
The interpretation of the pooled sensitivity of IgM/A and IgG resulted in the highest values (range 14–71% on day 2–7; 88–94% on day 8–18). |
T21 |
1176-1240 |
Sentence |
denotes |
Overall, the specificity of the assays was high (range 79–100%). |
T22 |
1241-1380 |
Sentence |
denotes |
Among 145 retrospective cases, 3 cases (2%) remained negative after sequential molecular testing but positive on final SARS-CoV-2 serology. |
T23 |
1381-1392 |
Sentence |
denotes |
Conclusion: |
T24 |
1393-1510 |
Sentence |
denotes |
Sensitivity of COVID-19 serological diagnosis was variable but consistently increased at >7 days after symptom onset. |
T25 |
1511-1532 |
Sentence |
denotes |
Specificity was high. |
T26 |
1533-1701 |
Sentence |
denotes |
Our data suggest that serology can complement molecular testing for diagnosis of COVID-19, especially for patients presenting the 2nd week after symptom onset or later. |